Arihant Agarwal

I had a question with regard to your group company, Themis Medicare. An d post the merger, near the acquisition that you have, the Sanofi brands and MBJ, what are the benefits that can actually move towards formulation for Themis? Do you see that happening over the next 1 to 2 years where I think a formulation which is currently outsourced, will eventually move towards Themis?